secwatch.observer — SEC 8-K summary
======================================

Issuer:     AMGEN INC (AMGN)
CIK:        0000318154
Form:       8-K
Filed at:   2022-12-02T23:59:59+00:00
Accession:  0001193125-22-297131
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Amgen confirms potential all-cash offer for Horizon Therapeutics
----------------------------------------------------------------

- Amgen states any offer for Horizon will be solely in cash.
- No certainty that a formal offer will be made; further updates expected.
- Disclosure follows Horizon's Rule 2.4 announcement; made under Irish Takeover Rules.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/318154/000119312522297131/0001193125-22-297131-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/318154/000119312522297131/d424230d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-297131

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer